First Gene Therapy for Hemophilia B

First Gene Therapy for Hemophilia B

Earlier this week, the etranacogene dezaparvovec (Hemgenix) made history as the first gene therapy approved by the US Food and Drug Administration (FDA) for the treatment of the rare genetic disorder hemophilia B. Patients with hemophilia B lack the ability to make a...